Array Biopharma (ARRY) Tops Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $4.80 -3.61%
Financial Fact:
Interest expense: -2.98M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Interest expense: -2.98M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Array Biopharma (NASDAQ: ARRY) reported Q3 EPS of ($0.17), $0.03 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $64.7 million versus the consensus estimate of $54.04 million.
For earnings history and earnings-related data on Array Biopharma (ARRY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Prenetics Global (PRE) Tops Q2 EPS by 18c
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
